供应WHO19/166可溯源国际标准物质胰岛素样生长因子I,用于免疫测定

供应WHO19/166可溯源国际标准物质胰岛素样生长因子I,用于免疫测定

产品详情如下,更多产品价格和货期,请咨询客服!

The WHO International Standard for Insulin-like Growth Factor-I (IGF-I),recombinant, human, is the primary reference material for the calibration of IGF-I immunoassays. This preparation, coded 19/166, containing recombinant human IGF-I, was ampouled and evaluated for its suitability to serve as a WHO International Standard by international collaborative study. It was established as the 2

nd International Standard for Insulin-like growth factor-I, recombinant, human, by the Expert Committee for Biological Standardization of the World Health Organization in October 2020. It replaces the 1st International Standard, for Insulin-like growth factor-I (IGF-I), recombinant, human, coded 02/254. WHO19/166

The material is not of human or bovine origin. As with all materials of biological origin, this preparation should be regarded as potentially hazardous to health. It should be used and discarded according to your own laboratory’s safety procedures. Such safety procedures should include the wearing of protective gloves and avoiding the generation of aerosols. Care should be exercised in opening ampoules or vials, to avoid cuts. 可溯源国际标准物质胰岛素样生长因子I,用于免疫测定

世界卫生组织的重组人胰岛素样生长因子-I(IGF-I)国际标准是校准IGF-I免疫分析的主要参考材料。该制剂编码19/166,含有重组人IGF-I,通过国际合作研究对其作为世界卫生组织国际标准的适用性进行安瓿装和评估。它被建立为2世界卫生组织生物标准化专家委员会于2020年10月制定的第二个胰岛素样生长因子-I重组人国际标准。它取代了第一个国际标准,胰岛素样生长因子-I(IGF-I),重组,人,编码02/254。

该材料不是人类或牛的来源。与所有生物来源的材料一样,这种制剂应被视为对健康有潜在危害。应根据您自己实验室的安全程序使用和丢弃它。此类安全程序应包括佩戴防护手套和避免产生气溶胶。打开安瓿或小瓶时应小心,以避免割伤。